Filter Search Results

Resources for Researchers

NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.

Showing results filtered by:
ClEAR ALL
Antimicrobial Drug Resistance
21 Results

ACTG Network Laboratory (ACTG NL)

The ACTG NL consists of Core Laboratory groups in immunology, pharmacology, virology and TB.

ARLG Virtual Biorepository Strain Catalogue

The ARLG biorepositories were created to aid in the development and evaluation of novel diagnostic tests and laboratory techniques, study mechanisms of resistance, generate preliminary data for study concepts, and support/mentor early-stage investigators pursuing research in the field of antibact

Biocontainment Laboratory: Boston University National Emerging Infectious Diseases Laboratory

The National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national network of secure facilities studying infectious diseases that are—or have the potential to become—major public health concerns

Biocontainment Laboratory: Rutgers University

The Rutgers University Regional Biocontainment Laboratory is one of the NIAID-supported Biocontainment Laboratories. The RBL is a highly secure facility designed to provide an ultra-safe work environment for scientists and support staff, as well as the public at large.

Biocontainment Laboratory: Tufts University

The Tufts New England Regional Biosafety Laboratory (RBL) is one of the NIAID-supported Regional Biocontainment Laboratories.

Biocontainment Laboratory: University of Tennessee

The University of Tennessee Regional Biocontainment Laboratory (RBL) is one of the NIAID-supported Biocontainment Laboratories.

Bioinformatics and Computational Biosciences Branch Services

The Bioinformatics and Computational Biosciences Branch (BCBB) offers a suite of scientific services and resources for the NIAID research community and its collaborators. BCBB provides expertise and computational solutions to researchers at all levels of experience.

Biopharmaceutical Product Development Services

Provides services to facilitate preclinical development of materials that are derived from biotechnology processes. Services will be conducted at the appropriate regulatory compliance level dependent on the stage of product development.

Genes Unknown in Acinetobacter baumannii (GUNK)

GUNK center is part of the NIAID Functional Genomics Program. This center was created to investigate the role of previously uncharacterized genes of A. baumannii in its ability to cause human disease. Three projects have been established to:

In Vitro Assessment for Antimicrobial Activity Program

The In Vitro Assessment for Antimicrobial Activity program provides capability in a broad range of in vitro assessments to evaluate promising candidate countermeasures for antimicrobial activity against microbial pathogens and vectors, including those derived from clinical speci

Interventional Agent Development Services

The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins.

Note: Devices are excluded.

NIAID Microbiome Program: Gnotobiotic Animal Facility

The Gnotobiotic Animal Facility houses purchased experimental mice in experimental isolators that serve as important resources for researchers studying the microbiome. The mice in this facility are germ-free, i.e., born and raised in absence of live microbes.

NIAID Microbiome Program: Sequencing

NIAID’s microbiome sequencing facility studies the structure and function of the microbiome associated with various hosts and body sites. This facility has one dedicated team and is equipped with an Ilumina MiSeq, which can sequence whole genomes or specific amplicons.

PATRIC (Bacterial Bioinformatics Resource Center)

PATRIC, one of the NIAID-funded Bioinformatics Resource Centers, is an information system designed to support the biomedical research community’s work on bacterial infectious diseases via integration of vital pathogen information with rich data and analysis tools.

Phase I Clinical Trial Units for Therapeutics

The Phase I Clinical Trial Units for Therapeutics support the design, development, implementation, and conduct of Phase I clinical trials to assess safety, pharmacokinetics, and/or pharmacodynamics of licensed and investigational therapeutic products, including immunomodulatory agents and monoclo

Preclinical Models of Infectious Disease

This contract program supports the development and refinement of animal models and animal replacement technologies and provides in vivo preclinical testing services, ranging from screening and proof-of-concept to GLP efficacy studies.

Structural Genomics Centers for Infectious Diseases: Resources

The Structural Genomics Centers for Infectious Diseases provide the research community with:

Systems Biology Consortium Resources

The Systems Biology Consortium for Infectious Diseases is a community of systems biologists who aim to integrate experimental biology and computational tools and modeling across temporal and spatial scales towards a better understanding of infectious diseases.

Therapeutic Development Services

The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis, or treatment of disease caused by a pathogen or certain toxins.

Vaccine and Treatment Evaluation Units (VTEUs) Services

The Vaccine and Treatment Evaluation Units (VTEUs), supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960s, comprise a consortium of contracts with academic centers and organizations that provides a ready resource for the conduct of clinical trials to evaluate pr

Vaccine Development Services

The Vaccine Development Services program offers a collection of preclinical services to support the development of vaccines intended for use in the investigation, control, prevention, and treatment of a wide range of infectious agents (other than HIV).